Gastric Feeding Tubes

2

Review clinical trials related to Gastric Feeding Tubes. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

TubeClear System Evaluation in Pediatric Patients

Enteral access devices (EADs) provide necessary hydration, nutrition, and medications to numerous patients in hospitals across the United States. When patient's EAD becomes clogged it can delay administration of important nutrition and medications which can cause adverse effects such as malnutrition, and dehydration, especially in pediatric patients. Traditional methods of unclogging EADs can require the use of special enzymes or chemicals but these produce a variable rate of success. The TubeClear system has been developed to help alleviate the need for use of special enzymes or chemicals and to provide a quick, safe alternative for those with a clogged or sluggish EAD all while at the patient's bedside. This system prevents the need for subsequent exposure to radiation and contrast media for confirmation of EAD location after replacement.

Participants needed: 20
Trial details
Age: 0-17Biological sex: AllType: InterventionalSponsor: Children's Mercy Hospital Kansas CityUpdated: Jun 5, 2026
Eligibility criteria

Males or females under the age of 18 for the entire duration of the study proced... [+4]

Wards of the State [+8]

Status: Recruiting

Gastric Ultrasound Feeding Tube Placement Confirmation Study

Objective This study aims to assess the accuracy and reliability of ultrasound in determining the correct placement of gastric feeding tubes (GFTs) in intensive care patients. Study Design A diagnostic study will be conducted to evaluate the efficacy of ultrasound in determining GFT placement in all ICU patients who require GFT placement. Patients will undergo ultrasound by an ultrasonographer (USG) after receiving a new or replaced GFT. The USG will assess the presence or absence of a "mosaic sign" after insufflation of 20 mL of air through the GFT. The mosaic sign indicates proper GFT placement in the stomach. Methods All ultrasonographic measurements will be recorded and saved in a central picture archiving and communication system (PACS). The images will be labeled with the deepness of the GFT (20 cm, 50 cm, or tracheobronchial) and anonymized before being presented to an intensivist expert in USG for interpretation. Hypothesis A 20 mL air insufflation via a GFT at the esophageal level or via a suction catheter in the tracheobronchial system will not produce a "mosaic sign" on ultrasound. This sign will only be present if the GFT is properly positioned in the stomach.

Participants needed: 58
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Leiden University Medical CenterUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Being tracheally intubated [+1]

Need a gastric feeding tube [+5]